Press Release Health Activists call on Gov. Hochul to Declare Diabetes Health Emergency as Amputations Soar

“Horror story” should spark state response, but does not amputations jumped 84 percent in decade leading up to the pandemic, jumped even more since
cases of diabetes-linked blindness, dialysis soar as well state refuses to fund evidence-based self-care programs proven to lower diabetes risks, which would save thousands of lives and billions of tax dollars

Happy, Healthy Holiday Tips — Johns Hopkins Children’s Center Experts Available to Discuss Staying Safe and Healthy this Holiday Season

Navigating RSV, COVID-19 and the Flu   As more people travel and gather with family and friends this holiday season, cases of COVID-19, RSV and the flu are high and, in some areas, rising across the country. How can we keep…

Redesigning diabetes technology to detect low blood sugar in older adults with diabetes and Alzheimer’s disease

Regenstrief Institute Research Scientist April Savoy, PhD, a human factors engineer and health services researcher, is developing and testing user-friendly health information tools and technology designed to enhance accessibility and value to older adults with both diabetes and Alzheimer’s disease, and their caregivers.

Published Real World Evidence Demonstrates KidneyIntelX™ Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease

Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces the publication of new real-world evidence (RWE) in Primary Care and Community Health demonstrating the Company’s KidneyIntelX bioprognostic™ test resulted in changed clinical decision making for patients in the early-stage of diabetic kidney disease (DKD) being cared for within the Mount Sinai Health System’s Population Health Ambulatory Pharmacy and Condition Management programs.

‘You can always make a change’: 15-Year-Old Johns Hopkins Patient with Type 2 Diabetes Thrives Almost 2 Years After Diagnosis

November is National Diabetes Awareness Month. Youth onset type 2 diabetes is rising worldwide, and a recent study by researchers at Johns Hopkins Children’s Center, published in the Journal of Pediatrics, documented a steep rise in new diagnoses of type 2 diabetes among children during the early part of the COVID-19 pandemic

UC San Diego Awarded $8M to Expand Stem Cell Therapy Clinical Trials

UC San Diego Alpha Stem Cell Clinic awarded $8M to expand clinical trials of novel stem cell therapies. The CIRM award will advance partnerships between academic and industry experts in San Diego to expedite clinical trials for patients with difficult-to-treat diseases.

UT Southwestern scientists among top 1% of highly cited researchers across the globe

More than 20 UT Southwestern Medical Center scientists are among the 2022 Highly Cited Researchers listed in the top 1% of researchers from across the globe

People with diabetes may benefit more from a pancreas transplant than other treatments

Results of pancreas transplantation continue to improve and up to 90% of recipients with diabetes enjoy freedom from both insulin therapy and the need for close glucose monitoring following the procedure, according to a new paper published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

Diabetes Awareness Month

Diabetes is a chronic health condition that impacts how the body turns food into energy. More than 37 million people in the United States have Type 2 diabetes, the most common form of the metabolic disorder, according to the Centers for Disease Control and Prevention. An additional 96 million adults have prediabetes and most of them are unaware they are developing a serious chronic disease.

El banco biológico Sangre Por Salud Biobank ayuda a cubrir la necesidad de la diversidad en la investigación sobre la genética

Desde la enfermedad de Alzheimer y el asma hasta la diabetes y los medicamentos para quimioterapia, los investigadores de Mayo Clinic están utilizando el banco biológico Sangre Por Salud Biobank en Arizona, el cual es una fuente abundante de especímenes biológicos que amplía la diversidad en la investigación médica.

New Startup Develops Potential Cure for Type 1 Diabetes

Insulin injections to treat Type 1 diabetes could become a thing of the past, but finding the cure faces many challenges. Although transplanting insulin-producing cells represents a promising approach, this cell therapy requires immunosuppression to prevent rejection. Georgia Tech researchers have developed a new biomaterial called iTOL-100 that could cure Type 1 diabetes by inducing immune acceptance of curative transplanted cells without immunosuppression.

What Retina Specialists Want You to Know About Diabetes and Vision

If you’re living with Type 1 or Type 2 diabetes, you likely know how the condition can impact your overall health. But, focusing on how diabetes can affect your vision can go a long way toward maintaining your clear view of the world, according to the American Society of Retina Specialists (ASRS).

New onset chronic kidney disease in people with diabetes highest among ethnic, racial minorities

New onset chronic kidney disease (CKD) in people with diabetes is highest among racial and ethnic minority groups compared with white persons, a UCLA-Providence study finds. The study, published as a letter to the editor in the New England Journal of Medicine, found that new onset CKD rates were higher by approximately 60%, 40%, 33%, and 25% in the Native Hawaiian/Pacific Islander, Black, American Indian/Alaska Native, and Hispanic/Latino populations, respectively, compared to white persons with diabetes.

Ochsner Health Reveals New Findings: Digital Health Pilot Dramatically Improves Outcomes for Medicaid Patients Battling Chronic Diseases, Among First to Do So

The statistically and clinically significant results of the pilot program– one of the first in the country – showed that enrollment in Ochsner Digital Medicine brought nearly half of all out-of-control Hypertension patients under control at only 90 days.

Cleveland Clinic Researchers Identify Diabetes Drug Metformin as Potential Atrial Fibrillation Treatment in Collaborative Research

Cleveland Clinic researchers have identified a common diabetes medication, metformin, as a possible treatment for atrial fibrillation.

The study, published in Cell Reports Medicine, built on ongoing collaborative Cleveland Clinic research to support further investigation into metformin as a drug repurposing candidate. Researchers used advanced computation and genetic sequencing to determine that metformin’s targets overlap significantly with genes dysregulated in atrial fibrillation.

Muscle Models Mimic Diabetes, Inform Personalized Medicine

Scientists are using in vitro skeletal muscle engineering to gain a better understanding of the complex genetic and environmental factors underlying diabetes, putting lab-grown, healthy skeletal muscle tissues in a state resembling diabetes or growing skeletal muscle from diabetic patients’ muscle stem cells. In Biophysics Reviews, researchers describe how skeletal muscle engineering has advanced significantly during the past few decades and recent developments that make it easier to explore diabetes in humans and have led to more personalized medicine.

New Risk Score Predicts Mortality for Atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Replacement

Mount Sinai researchers develop new risk stratification tool to optimize patient care and outcomes after TAVR

Mayo Clinic Healthcare expert shares heart failure signs, risk factors people may not be aware of

Heart failure may seem like a disease of advanced age, but it can develop at any time in life. And, in many cases, it can be prevented or treated. In this expert alert, Gosia Wamil, M.D., Ph.D., a cardiologist at Mayo Clinic Healthcare in London, explains risk factors, symptoms that people may not be aware of and how heart failure is treated.

Enfermedad de las arterias periféricas señala problemas cardiovasculares en corazón, cerebro y piernas

Si no ha escuchado hablar sobre la enfermedad de las arterias periféricas, no es la única persona que no lo ha hecho. Aunque los médicos y las organizaciones de atención de la salud han concienciado mejor acerca de que la enfermedad cardíaca es la primera causa de muerte en todo el mundo,

A doença arterial periférica pode ser um sinal de problema cardiovascular no coração, cérebro e pernas

Se você nunca ouviu falar da doença arterial periférica, você não está sozinho. Apesar de s médicos e as organizações de saúde já terem avançado na conscientização de que a doença cardíaca é a principal causa de morte em todo o mundo, a doença arterial periférica, mesmo sendo parte das doenças cardíacas, não é muito conhecida.

Journal of Medical Internet Research | Blood Pressure Monitoring, a Digital Tool for Diabetes

JMIR Publications recently published “Blood Pressure Monitoring as a Digital Health Tool for Improving Diabetes Clinical Outcomes: Retrospective Real-world Study” in the Journal of Medical Internet Research (JMIR), which reported that there is a lack of understanding of the association between blood glucose (BG) and blood pressure (BP) levels when using digital health tools.

JMIR Diabetes | Digital Diabetes Prevention Program on Weight and Physical Activity

JMIR Publications recently published “A 12-Month Follow-Up of the Effects of a Digital Diabetes Prevention Program (VP Transform for Prediabetes) on Weight and Physical Activity Among Adults With Prediabetes: Secondary Analysis” in JMIR Diabetes which reported that previous research has demonstrated the efficacy of a diabetes prevention program (DPP) in lifestyle modifications that can prevent or delay the onset of type 2 diabetes among individuals at risk.

MedStar Washington Hospital Center Again Named Among Nation’s Top 50 for Heart Care

MedStar Washington Hospital Center has again achieved national ranking for Cardiology & Heart Surgery in the 2022-23 U.S. News & World Report “Best Hospitals” rankings. It moved up to No. 28, from No. 30 last year. It is the only nationally recognized heart program of its kind in the Washington metropolitan area. MedStar Washington also earned “high performing” ratings in cancer, gastroenterology & GI surgery, Urology, and in 12 common procedures and conditions.

Hormone Infusion Improves Pancreatic Insulin Production in Cystic Fibrosis Patients with or at Risk for Diabetes

Medication therapy based on the hormone glucagon-like peptide-1(GLP-1) may help regulate natural insulin production in cystic fibrosis, potentially offering a better way to prevent and ultimately manage diabetes than daily insulin injections